Home » Topics » BioWorld Science, Dermatologic

BioWorld Science, Dermatologic
RSS

Phoenix Tissue Repair studies PTR-01 in patients with recessive dystrophic epidermolysis bullosa

Feb. 11, 2019

BREEZE-AD1 and AD2 studies of baricitinib in atopic dermatitis meet primary endpoints

Feb. 4, 2019

Allakos reports phase II data on AK-002 in cholinergic urticaria and symptomatic dermographism

Jan. 30, 2019

AS-2762900-00 prevents epidermal hyperplasia in xenograft model of psoriasis

Jan. 25, 2019

Bermekimab demonstrates efficacy in confirmatory study in patients with hidradenitis suppurativa

Jan. 24, 2019

Phase III study of NexoBrid meets primary and secondary endpoints

Jan. 23, 2019

Ralexar Therapeutics patents oxysterols receptor LXR-beta agonists

Jan. 17, 2019

Enrollment ongoing in first-in-human study of PBF-1650

Jan. 14, 2019

Blade Therapeutics patents calpain inhibitors

Jan. 11, 2019

Preclinical data presented for sarecycline for the treatment of acne vulgaris

Jan. 11, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 4, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...